Core-sheath implant device having an inner core lobe
View Patent ↗The core-sheath implant device allows for a bioactive agent release profile that can be tailored to a particular therapy. The device features one or more lobes extending from an inner core at least partially through the outer sheath. Depending on the particular design of such an implant device, a variety of release profiles can be achieved.
1. An implant device, comprising:
a. an outer sheath comprising a biocompatible polymer and having an exposed longitudinal sheath surface and exposed proximal and distal end surfaces; and
b. an inner core comprising a bioactive agent and having:
i. a longitudinal core surface that is completely surrounded by the sheath; and
ii. a longitudinal lobe extending outwardly from the longitudinal core surface at least partially through the outer sheath and having a longitudinal lobe surface; wherein at least a portion of the longitudinal lobe surface is closer to the exposed longitudinal sheath surface than any portion of the longitudinal core surface.
2. The implant device of claim 1 , wherein the inner core has an exposed proximal core end surface or an exposed distal core end surface.
3. The implant device of claim 1 , wherein the implant device is cylindrical.
4. The implant device of claim 1 , wherein the inner core is substantially coextensive with the outer sheath.
5. The implant device of claim 1 , wherein the longitudinal lobe extends only partially through the outer sheath.
6. The implant device of claim 1 , wherein a portion of the longitudinal lobe surface is surrounded by the outer sheath, and a portion of the longitudinal lobe surface is exposed.
7. The implant device of claim 1 , wherein the biocompatible polymer of the outer sheath comprises poly(lactide), poly(glycolide), poly(caprolactone), poly(lactide-co-glycolide), or a copolymer, mixture, or blend thereof.
8. The implant device of claim 1 , wherein the inner core comprises a biocompatible polymer that is the same as or different from the biocompatible polymer of the outer sheath.
9. The implant device of claim 8 , wherein the biocompatible polymer of the inner core comprises poly(lactide), poly(glycolide), poly(caprolactone), poly(lactide-co-glycolide), or a copolymer, mixture, or blend thereof.
10. The implant device of claim 1 , wherein the outer sheath comprises a bioactive agent that is the same as or different from the bioactive agent of the inner core.